Cargando…
Flow cytometry can reliably capture gut microbial composition in healthy adults as well as dysbiosis dynamics in patients with aggressive B-cell non-Hodgkin lymphoma
Modulation of commensal gut microbiota is increasingly recognized as a promising strategy to reduce mortality in patients with malignant diseases, but monitoring for dysbiosis is generally not routine clinical practice due to equipment, expertise and funding required for sequencing analysis. A low-t...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9154785/ https://www.ncbi.nlm.nih.gov/pubmed/35634713 http://dx.doi.org/10.1080/19490976.2022.2081475 |
_version_ | 1784718104954142720 |
---|---|
author | Schmiester, Maren Maier, René Riedel, René Durek, Pawel Frentsch, Marco Kolling, Stefan Mashreghi, Mir-Farzin Jenq, Robert Zhang, Liangliang Peterson, Christine B. Bullinger, Lars Chang, Hyun-Dong Na, Il-Kang |
author_facet | Schmiester, Maren Maier, René Riedel, René Durek, Pawel Frentsch, Marco Kolling, Stefan Mashreghi, Mir-Farzin Jenq, Robert Zhang, Liangliang Peterson, Christine B. Bullinger, Lars Chang, Hyun-Dong Na, Il-Kang |
author_sort | Schmiester, Maren |
collection | PubMed |
description | Modulation of commensal gut microbiota is increasingly recognized as a promising strategy to reduce mortality in patients with malignant diseases, but monitoring for dysbiosis is generally not routine clinical practice due to equipment, expertise and funding required for sequencing analysis. A low-threshold alternative is microbial diversity profiling by single-cell flow cytometry (FCM), which we compared to 16S rRNA sequencing in human fecal samples and employed to characterize longitudinal changes in the microbiome composition of patients with aggressive B-cell non-Hodgkin lymphoma undergoing chemoimmunotherapy. Diversity measures obtained from both methods were correlated and captured identical trends in microbial community structures, finding no difference in patients’ pretreatment alpha or beta diversity compared to healthy controls and a significant and progressive loss of alpha diversity during chemoimmunotherapy. Our results highlight the potential of FCM-based microbiome profiling as a reliable and accessible diagnostic tool that can provide novel insights into cancer therapy-associated dysbiosis dynamics. |
format | Online Article Text |
id | pubmed-9154785 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-91547852022-06-01 Flow cytometry can reliably capture gut microbial composition in healthy adults as well as dysbiosis dynamics in patients with aggressive B-cell non-Hodgkin lymphoma Schmiester, Maren Maier, René Riedel, René Durek, Pawel Frentsch, Marco Kolling, Stefan Mashreghi, Mir-Farzin Jenq, Robert Zhang, Liangliang Peterson, Christine B. Bullinger, Lars Chang, Hyun-Dong Na, Il-Kang Gut Microbes Brief Report Modulation of commensal gut microbiota is increasingly recognized as a promising strategy to reduce mortality in patients with malignant diseases, but monitoring for dysbiosis is generally not routine clinical practice due to equipment, expertise and funding required for sequencing analysis. A low-threshold alternative is microbial diversity profiling by single-cell flow cytometry (FCM), which we compared to 16S rRNA sequencing in human fecal samples and employed to characterize longitudinal changes in the microbiome composition of patients with aggressive B-cell non-Hodgkin lymphoma undergoing chemoimmunotherapy. Diversity measures obtained from both methods were correlated and captured identical trends in microbial community structures, finding no difference in patients’ pretreatment alpha or beta diversity compared to healthy controls and a significant and progressive loss of alpha diversity during chemoimmunotherapy. Our results highlight the potential of FCM-based microbiome profiling as a reliable and accessible diagnostic tool that can provide novel insights into cancer therapy-associated dysbiosis dynamics. Taylor & Francis 2022-05-29 /pmc/articles/PMC9154785/ /pubmed/35634713 http://dx.doi.org/10.1080/19490976.2022.2081475 Text en © 2022 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Brief Report Schmiester, Maren Maier, René Riedel, René Durek, Pawel Frentsch, Marco Kolling, Stefan Mashreghi, Mir-Farzin Jenq, Robert Zhang, Liangliang Peterson, Christine B. Bullinger, Lars Chang, Hyun-Dong Na, Il-Kang Flow cytometry can reliably capture gut microbial composition in healthy adults as well as dysbiosis dynamics in patients with aggressive B-cell non-Hodgkin lymphoma |
title | Flow cytometry can reliably capture gut microbial composition in healthy adults as well as dysbiosis dynamics in patients with aggressive B-cell non-Hodgkin lymphoma |
title_full | Flow cytometry can reliably capture gut microbial composition in healthy adults as well as dysbiosis dynamics in patients with aggressive B-cell non-Hodgkin lymphoma |
title_fullStr | Flow cytometry can reliably capture gut microbial composition in healthy adults as well as dysbiosis dynamics in patients with aggressive B-cell non-Hodgkin lymphoma |
title_full_unstemmed | Flow cytometry can reliably capture gut microbial composition in healthy adults as well as dysbiosis dynamics in patients with aggressive B-cell non-Hodgkin lymphoma |
title_short | Flow cytometry can reliably capture gut microbial composition in healthy adults as well as dysbiosis dynamics in patients with aggressive B-cell non-Hodgkin lymphoma |
title_sort | flow cytometry can reliably capture gut microbial composition in healthy adults as well as dysbiosis dynamics in patients with aggressive b-cell non-hodgkin lymphoma |
topic | Brief Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9154785/ https://www.ncbi.nlm.nih.gov/pubmed/35634713 http://dx.doi.org/10.1080/19490976.2022.2081475 |
work_keys_str_mv | AT schmiestermaren flowcytometrycanreliablycapturegutmicrobialcompositioninhealthyadultsaswellasdysbiosisdynamicsinpatientswithaggressivebcellnonhodgkinlymphoma AT maierrene flowcytometrycanreliablycapturegutmicrobialcompositioninhealthyadultsaswellasdysbiosisdynamicsinpatientswithaggressivebcellnonhodgkinlymphoma AT riedelrene flowcytometrycanreliablycapturegutmicrobialcompositioninhealthyadultsaswellasdysbiosisdynamicsinpatientswithaggressivebcellnonhodgkinlymphoma AT durekpawel flowcytometrycanreliablycapturegutmicrobialcompositioninhealthyadultsaswellasdysbiosisdynamicsinpatientswithaggressivebcellnonhodgkinlymphoma AT frentschmarco flowcytometrycanreliablycapturegutmicrobialcompositioninhealthyadultsaswellasdysbiosisdynamicsinpatientswithaggressivebcellnonhodgkinlymphoma AT kollingstefan flowcytometrycanreliablycapturegutmicrobialcompositioninhealthyadultsaswellasdysbiosisdynamicsinpatientswithaggressivebcellnonhodgkinlymphoma AT mashreghimirfarzin flowcytometrycanreliablycapturegutmicrobialcompositioninhealthyadultsaswellasdysbiosisdynamicsinpatientswithaggressivebcellnonhodgkinlymphoma AT jenqrobert flowcytometrycanreliablycapturegutmicrobialcompositioninhealthyadultsaswellasdysbiosisdynamicsinpatientswithaggressivebcellnonhodgkinlymphoma AT zhangliangliang flowcytometrycanreliablycapturegutmicrobialcompositioninhealthyadultsaswellasdysbiosisdynamicsinpatientswithaggressivebcellnonhodgkinlymphoma AT petersonchristineb flowcytometrycanreliablycapturegutmicrobialcompositioninhealthyadultsaswellasdysbiosisdynamicsinpatientswithaggressivebcellnonhodgkinlymphoma AT bullingerlars flowcytometrycanreliablycapturegutmicrobialcompositioninhealthyadultsaswellasdysbiosisdynamicsinpatientswithaggressivebcellnonhodgkinlymphoma AT changhyundong flowcytometrycanreliablycapturegutmicrobialcompositioninhealthyadultsaswellasdysbiosisdynamicsinpatientswithaggressivebcellnonhodgkinlymphoma AT nailkang flowcytometrycanreliablycapturegutmicrobialcompositioninhealthyadultsaswellasdysbiosisdynamicsinpatientswithaggressivebcellnonhodgkinlymphoma |